3 research outputs found
SM with influence on virulence of fungi in the respective host system.
<p>Animal cell: <b>Gliotoxin</b> acts on the mitochondrial protein Bak, which leads to apoptosis and inhibits the activation of NFκB through blocking proteasomal activity; <b>DHN-melanin</b> from <i>A. fumigatus</i> inhibits vH<sup>+</sup>-ATPase activity and therefore acidification of the phagolysosome, which counteracts killing of the conidia. Fungi: <b>Siderophores</b> are released by the fungus to ensure iron availability; <b>DHN-melanin</b> from plant pathogens is crucial for appressorium formation and counteracting reactive oxygen species (ROS) produced by the plant through hypersensitive response (HR) to prevent the spread of fungal infection; <b>DOPA-melanin</b> produced by <i>C. neoformans</i> from external precursors is an important part of the fungal capsule. Plant cell: <b>Cytochalasins</b> block cytokinesis; <b>T-Toxin</b> inhibits mitochondrial energy production; <b>Fumonisin</b>, <b>AAL-Toxin</b>, and <b>Cyperin</b> affect the membrane integrity; <b>Auxin</b> and <b>Gibberellins</b> act as phytohormones and alter transcription activity; <b>HC-Toxin</b> inhibits histone deacetylase; after light-driven activation both <b>Cercosporin</b> and <b>Elsinochromes</b> produce ROS, which damage the cell; <b>Sirodesmin</b> induces ROS and the formation of protein-conjugates; <b>Tentoxin</b> inhibits chloroplastidial energy production; <b>Fusicoccin</b> mediates irreversible stomata opening; <b>Beticolin</b> forms pores in the membrane and leads to leakage of the cell.</p
Gliotoxin Biosynthesis: Structure, Mechanism, and Metal Promiscuity of Carboxypeptidase GliJ
The
formation of glutathione (GSH) conjugates, best known from
the detoxification of xenobiotics, is a widespread strategy to incorporate
sulfur into biomolecules. The biosynthesis of gliotoxin, a virulence
factor of the human pathogenic fungus <i>Aspergillus fumigatus</i>, involves attachment of two GSH molecules and their sequential decomposition
to yield two reactive thiol groups. The degradation of the GSH moieties
requires the activity of the Cys–Gly carboxypeptidase GliJ,
for which we describe the X-ray structure here. The enzyme forms a
homodimer with each monomer comprising one active site. Two metal
ions are present per proteolytic center, thus assigning GliJ to the
diverse family of dinuclear metallohydrolases. Depending on availability,
Zn<sup>2+</sup>, Fe<sup>2+</sup>, Fe<sup>3+</sup>, Mn<sup>2+</sup>, Cu<sup>2+</sup>, Co<sup>2+</sup>, or Ni<sup>2+</sup> ions are accepted
as cofactors. Despite this high metal promiscuity, a preference for
zinc versus iron and manganese was noted. Mutagenesis experiments
revealed details of metal coordination, and molecular modeling delivered
insights into substrate recognition and processing by GliJ. The latter
results suggest a reaction mechanism in which the two scissile peptide
bonds of one gliotoxin precursor molecule are hydrolyzed sequentially
and in a given order
Star-Shaped Drug Carriers for Doxorubicin with POEGMA and POEtOxMA Brush-like Shells: A Structural, Physical, and Biological Comparison
The
synthesis of amphiphilic star-shaped poly(ε-caprolactone)-<i>block</i>-poly(oligo(ethylene glycol)methacrylate)s ([PCL<sub>18</sub>-<i>b</i>-POEGMA]<sub>4</sub>) and poly(ε-caprolactone)-<i>block</i>-poly(oligo(2-ethyl-2-oxazoline)methacrylate)s ([PCL<sub>18</sub>-<i>b</i>-POEtOxMA]<sub>4</sub>) is presented.
Unimolecular behavior in aqueous systems is observed with the tendency
to form loose aggregates for both hydrophilic shell types. The comparison
of OEGMA and OEtOxMA reveals that the molar mass of the macromonomer
in the hydrophilic shell rather than the mere length is the crucial
factor to form an efficiently stabilizing hydrophilic shell. A hydrophilic/lipophilic
balance of 0.8 is shown to stabilize unimolecular micelles in water.
An extensive in vitro biological evaluation shows neither blood nor
cytotoxicity. The applicability of the polymers as drug delivery systems
was proven by the encapsulation of the anticancer drug doxorubicin,
whose cytotoxic effect was retarded in comparison to the free drug